Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications | 60 | 2025 | 2971 | 4.870 |
Why?
|
Antipsychotic Agents | 32 | 2024 | 3078 | 4.470 |
Why?
|
Hot Flashes | 36 | 2020 | 329 | 4.430 |
Why?
|
Abnormalities, Drug-Induced | 15 | 2023 | 337 | 3.980 |
Why?
|
Depression, Postpartum | 19 | 2023 | 354 | 3.330 |
Why?
|
Antidepressive Agents | 46 | 2024 | 2903 | 3.050 |
Why?
|
Menopause | 28 | 2020 | 1657 | 2.800 |
Why?
|
Puerperal Disorders | 17 | 2024 | 304 | 2.360 |
Why?
|
Premenstrual Syndrome | 19 | 2017 | 111 | 2.240 |
Why?
|
Depressive Disorder, Major | 29 | 2025 | 4810 | 2.210 |
Why?
|
Depressive Disorder | 41 | 2023 | 3715 | 2.130 |
Why?
|
Pregnancy | 115 | 2025 | 30237 | 2.110 |
Why?
|
Estradiol | 19 | 2020 | 1947 | 2.090 |
Why?
|
Perimenopause | 16 | 2020 | 142 | 2.000 |
Why?
|
Registries | 21 | 2024 | 8351 | 1.930 |
Why?
|
Cyclohexanols | 8 | 2015 | 126 | 1.920 |
Why?
|
Prenatal Exposure Delayed Effects | 13 | 2024 | 2538 | 1.620 |
Why?
|
Psychotic Disorders | 16 | 2024 | 3276 | 1.480 |
Why?
|
Psychotropic Drugs | 8 | 2019 | 880 | 1.390 |
Why?
|
Estrogen Replacement Therapy | 16 | 2018 | 1205 | 1.320 |
Why?
|
Depression | 31 | 2025 | 8228 | 1.300 |
Why?
|
Mood Disorders | 11 | 2010 | 1127 | 1.260 |
Why?
|
Postpartum Period | 14 | 2024 | 1195 | 1.240 |
Why?
|
Antidepressive Agents, Second-Generation | 8 | 2018 | 490 | 1.240 |
Why?
|
Ultrasonography, Prenatal | 9 | 2016 | 1772 | 1.240 |
Why?
|
Postmenopause | 20 | 2018 | 2517 | 1.140 |
Why?
|
Mental Disorders | 16 | 2023 | 6869 | 1.120 |
Why?
|
Pregnancy Outcome | 13 | 2023 | 2971 | 1.090 |
Why?
|
Citalopram | 8 | 2015 | 402 | 1.040 |
Why?
|
Climacteric | 6 | 2003 | 57 | 0.970 |
Why?
|
Benzodiazepines | 5 | 2022 | 1137 | 0.950 |
Why?
|
Hospitals, General | 7 | 2024 | 804 | 0.950 |
Why?
|
Female | 238 | 2025 | 396520 | 0.940 |
Why?
|
Psychiatric Status Rating Scales | 33 | 2021 | 6020 | 0.880 |
Why?
|
Menstrual Cycle | 8 | 2007 | 539 | 0.870 |
Why?
|
Central Nervous System Stimulants | 2 | 2023 | 1168 | 0.860 |
Why?
|
Bipolar Disorder | 22 | 2019 | 5130 | 0.850 |
Why?
|
Infertility, Female | 4 | 2018 | 763 | 0.840 |
Why?
|
Vasomotor System | 6 | 2020 | 208 | 0.840 |
Why?
|
Postpartum Hemorrhage | 2 | 2024 | 275 | 0.830 |
Why?
|
Paroxetine | 4 | 2008 | 181 | 0.820 |
Why?
|
Pregnancy Trimester, First | 9 | 2023 | 917 | 0.800 |
Why?
|
Adult | 155 | 2025 | 223307 | 0.760 |
Why?
|
Fetal Heart | 3 | 2015 | 281 | 0.710 |
Why?
|
Fatty Acids, Omega-3 | 9 | 2015 | 1399 | 0.700 |
Why?
|
Massachusetts | 12 | 2024 | 8891 | 0.700 |
Why?
|
Uterus | 3 | 2013 | 661 | 0.680 |
Why?
|
Fluoxetine | 10 | 2005 | 732 | 0.670 |
Why?
|
Humans | 247 | 2025 | 766766 | 0.660 |
Why?
|
Leiomyoma | 4 | 2013 | 644 | 0.640 |
Why?
|
Methylphenidate | 1 | 2023 | 480 | 0.630 |
Why?
|
Anxiety | 11 | 2025 | 4670 | 0.630 |
Why?
|
Ultrasonography, Doppler, Color | 4 | 2007 | 234 | 0.630 |
Why?
|
Sleep Initiation and Maintenance Disorders | 10 | 2020 | 1104 | 0.620 |
Why?
|
Tetrahydrofolates | 1 | 2019 | 58 | 0.620 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 3 | 2023 | 3724 | 0.610 |
Why?
|
Reproduction | 4 | 2018 | 645 | 0.580 |
Why?
|
Piperazines | 4 | 2018 | 2547 | 0.580 |
Why?
|
Mass Screening | 8 | 2023 | 5454 | 0.580 |
Why?
|
Ethinyl Estradiol | 4 | 2017 | 111 | 0.580 |
Why?
|
Dietary Supplements | 6 | 2019 | 3429 | 0.570 |
Why?
|
Schizophrenia, Paranoid | 1 | 2017 | 102 | 0.560 |
Why?
|
Estrogens | 10 | 2018 | 1528 | 0.560 |
Why?
|
Substance Withdrawal Syndrome | 5 | 2019 | 627 | 0.550 |
Why?
|
Anxiety Disorders | 12 | 2013 | 2744 | 0.550 |
Why?
|
Sulfides | 1 | 2017 | 169 | 0.540 |
Why?
|
Antimanic Agents | 7 | 2019 | 523 | 0.530 |
Why?
|
Thiophenes | 2 | 2013 | 570 | 0.520 |
Why?
|
Drug Labeling | 1 | 2018 | 251 | 0.510 |
Why?
|
Affect | 10 | 2020 | 1494 | 0.500 |
Why?
|
Uterine Neoplasms | 4 | 2013 | 1424 | 0.490 |
Why?
|
Psychotherapy | 7 | 2003 | 1648 | 0.470 |
Why?
|
Breast Feeding | 10 | 2024 | 1363 | 0.470 |
Why?
|
Diabetes, Gestational | 3 | 2023 | 1263 | 0.470 |
Why?
|
Eicosapentaenoic Acid | 2 | 2015 | 565 | 0.460 |
Why?
|
Lithium | 9 | 2008 | 599 | 0.450 |
Why?
|
Prospective Studies | 29 | 2023 | 54871 | 0.450 |
Why?
|
Premenopause | 5 | 2007 | 1039 | 0.450 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2010 | 611 | 0.450 |
Why?
|
Fertilization | 2 | 2014 | 197 | 0.440 |
Why?
|
Prenatal Care | 2 | 2019 | 1158 | 0.440 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2018 | 503 | 0.440 |
Why?
|
Docosahexaenoic Acids | 3 | 2015 | 915 | 0.430 |
Why?
|
Lithium Compounds | 3 | 2017 | 226 | 0.430 |
Why?
|
Infant, Newborn, Diseases | 2 | 2018 | 587 | 0.430 |
Why?
|
Suicidal Ideation | 2 | 2023 | 1467 | 0.430 |
Why?
|
Middle Aged | 91 | 2022 | 223257 | 0.430 |
Why?
|
Suicide | 2 | 2023 | 1606 | 0.410 |
Why?
|
Trachea | 2 | 2016 | 1094 | 0.410 |
Why?
|
Premature Birth | 2 | 2023 | 1830 | 0.400 |
Why?
|
Heart Defects, Congenital | 7 | 2017 | 4712 | 0.400 |
Why?
|
Azabicyclo Compounds | 2 | 2009 | 66 | 0.400 |
Why?
|
Hypertriglyceridemia | 1 | 2015 | 292 | 0.400 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2016 | 1142 | 0.400 |
Why?
|
Double-Blind Method | 27 | 2017 | 12430 | 0.400 |
Why?
|
Hypnotics and Sedatives | 3 | 2011 | 1193 | 0.400 |
Why?
|
Yoga | 6 | 2015 | 277 | 0.390 |
Why?
|
Androstenes | 2 | 2017 | 177 | 0.390 |
Why?
|
Withholding Treatment | 2 | 2014 | 619 | 0.390 |
Why?
|
Obsessive-Compulsive Disorder | 5 | 2024 | 1495 | 0.370 |
Why?
|
Treatment Refusal | 2 | 2004 | 433 | 0.360 |
Why?
|
Transposition of Great Vessels | 1 | 2015 | 581 | 0.360 |
Why?
|
Young Adult | 26 | 2024 | 59939 | 0.360 |
Why?
|
Follicle Stimulating Hormone | 5 | 2011 | 731 | 0.360 |
Why?
|
Infant, Newborn | 24 | 2023 | 26389 | 0.360 |
Why?
|
Vagina | 6 | 2018 | 849 | 0.360 |
Why?
|
Neurotransmitter Uptake Inhibitors | 1 | 2010 | 36 | 0.350 |
Why?
|
Cesarean Section | 2 | 2018 | 1418 | 0.350 |
Why?
|
Treatment Outcome | 40 | 2020 | 65273 | 0.350 |
Why?
|
Panic Disorder | 5 | 2001 | 613 | 0.340 |
Why?
|
Parturition | 3 | 2023 | 453 | 0.340 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1673 | 0.330 |
Why?
|
Recurrence | 17 | 2018 | 8507 | 0.330 |
Why?
|
Severity of Illness Index | 22 | 2019 | 15908 | 0.320 |
Why?
|
Pre-Eclampsia | 2 | 2018 | 1256 | 0.320 |
Why?
|
Image Enhancement | 4 | 2010 | 2857 | 0.320 |
Why?
|
Vaginal Diseases | 3 | 2020 | 103 | 0.310 |
Why?
|
Sleep | 7 | 2014 | 4815 | 0.310 |
Why?
|
Placebos | 9 | 2014 | 1659 | 0.300 |
Why?
|
Hypercholesterolemia | 1 | 2015 | 1145 | 0.300 |
Why?
|
Imaging, Three-Dimensional | 3 | 2011 | 4047 | 0.300 |
Why?
|
Single-Blind Method | 6 | 2021 | 1587 | 0.300 |
Why?
|
Stress, Psychological | 3 | 2021 | 4527 | 0.300 |
Why?
|
Multicenter Studies as Topic | 1 | 2013 | 1733 | 0.290 |
Why?
|
Ovarian Neoplasms | 5 | 2007 | 4904 | 0.290 |
Why?
|
Menstruation Disturbances | 2 | 2006 | 140 | 0.290 |
Why?
|
Adolescent | 30 | 2022 | 88904 | 0.290 |
Why?
|
Vitamins | 1 | 2015 | 1631 | 0.280 |
Why?
|
Clonazepam | 7 | 2001 | 135 | 0.280 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2010 | 3359 | 0.280 |
Why?
|
Ovarian Cysts | 1 | 2007 | 107 | 0.280 |
Why?
|
Anti-Anxiety Agents | 4 | 2024 | 404 | 0.270 |
Why?
|
Secondary Prevention | 3 | 2019 | 1469 | 0.270 |
Why?
|
Sertraline | 3 | 2003 | 210 | 0.270 |
Why?
|
Milk, Human | 3 | 2007 | 490 | 0.270 |
Why?
|
Outpatients | 1 | 2014 | 1596 | 0.260 |
Why?
|
Pregnant Women | 3 | 2023 | 576 | 0.260 |
Why?
|
Cognition | 4 | 2021 | 7057 | 0.250 |
Why?
|
Fertilization in Vitro | 1 | 2013 | 1301 | 0.250 |
Why?
|
Maternal-Fetal Exchange | 3 | 2019 | 453 | 0.250 |
Why?
|
Contraceptives, Oral | 1 | 2007 | 559 | 0.240 |
Why?
|
Panic | 6 | 1991 | 103 | 0.240 |
Why?
|
Sudden Infant Death | 1 | 2007 | 293 | 0.230 |
Why?
|
Pregnancy Trimester, Third | 5 | 2017 | 587 | 0.230 |
Why?
|
Pattern Recognition, Automated | 1 | 2010 | 979 | 0.220 |
Why?
|
Lactation | 3 | 2021 | 392 | 0.220 |
Why?
|
Risk Factors | 32 | 2024 | 74881 | 0.220 |
Why?
|
Impulsive Behavior | 1 | 2006 | 345 | 0.220 |
Why?
|
Bupropion | 1 | 2005 | 303 | 0.210 |
Why?
|
Dibenzothiazepines | 1 | 2003 | 102 | 0.210 |
Why?
|
Infant | 10 | 2023 | 36461 | 0.210 |
Why?
|
Qualitative Research | 2 | 2024 | 3138 | 0.200 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2003 | 139 | 0.200 |
Why?
|
Life Change Events | 3 | 2009 | 956 | 0.200 |
Why?
|
Sweating | 4 | 2015 | 155 | 0.200 |
Why?
|
Antidepressive Agents, Tricyclic | 3 | 2014 | 427 | 0.200 |
Why?
|
Amphetamine | 1 | 2023 | 222 | 0.200 |
Why?
|
Acetates | 1 | 2003 | 314 | 0.190 |
Why?
|
Buspirone | 1 | 2022 | 80 | 0.190 |
Why?
|
Follow-Up Studies | 17 | 2023 | 39309 | 0.190 |
Why?
|
Sensitivity and Specificity | 11 | 2016 | 14652 | 0.190 |
Why?
|
Anticonvulsants | 7 | 2017 | 1921 | 0.190 |
Why?
|
Vitamin D | 1 | 2015 | 3270 | 0.190 |
Why?
|
Amines | 1 | 2003 | 280 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 14 | 2016 | 10745 | 0.190 |
Why?
|
Administration, Cutaneous | 5 | 2011 | 712 | 0.190 |
Why?
|
Case-Control Studies | 10 | 2021 | 22248 | 0.190 |
Why?
|
Endometriosis | 2 | 2003 | 868 | 0.190 |
Why?
|
Disease Progression | 1 | 2018 | 13640 | 0.180 |
Why?
|
Health Status Disparities | 1 | 2013 | 1880 | 0.180 |
Why?
|
Drug Administration Schedule | 9 | 2005 | 4853 | 0.180 |
Why?
|
Comorbidity | 11 | 2025 | 10580 | 0.180 |
Why?
|
Prevalence | 11 | 2017 | 15835 | 0.180 |
Why?
|
Valproic Acid | 5 | 2006 | 444 | 0.180 |
Why?
|
Hormone Replacement Therapy | 2 | 2003 | 751 | 0.180 |
Why?
|
Progesterone | 2 | 2020 | 752 | 0.180 |
Why?
|
Endometrium | 3 | 2013 | 406 | 0.180 |
Why?
|
Fallopian Tubes | 1 | 2001 | 179 | 0.170 |
Why?
|
Luteinizing Hormone | 1 | 2003 | 828 | 0.170 |
Why?
|
Tourette Syndrome | 1 | 2003 | 400 | 0.170 |
Why?
|
Mothers | 3 | 2024 | 2208 | 0.170 |
Why?
|
Affective Symptoms | 1 | 2002 | 418 | 0.170 |
Why?
|
Quality of Life | 8 | 2020 | 13476 | 0.160 |
Why?
|
Feedback | 1 | 2023 | 797 | 0.160 |
Why?
|
Interview, Psychological | 4 | 2017 | 810 | 0.160 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 5 | 2017 | 1988 | 0.160 |
Why?
|
Sodium Chloride | 1 | 2001 | 580 | 0.160 |
Why?
|
Perinatal Care | 1 | 2021 | 244 | 0.160 |
Why?
|
Ultrasonography, Doppler | 1 | 2001 | 464 | 0.160 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 2019 | 80 | 0.160 |
Why?
|
Phobic Disorders | 3 | 1990 | 440 | 0.150 |
Why?
|
Women's Health | 3 | 2016 | 2081 | 0.150 |
Why?
|
Exercise | 5 | 2015 | 5945 | 0.150 |
Why?
|
1-Naphthylamine | 1 | 1998 | 48 | 0.150 |
Why?
|
Abortifacient Agents, Nonsteroidal | 2 | 2012 | 65 | 0.150 |
Why?
|
Pilot Projects | 8 | 2025 | 8728 | 0.150 |
Why?
|
Prediabetic State | 1 | 2023 | 547 | 0.150 |
Why?
|
Canada | 1 | 2023 | 2126 | 0.140 |
Why?
|
Research Design | 6 | 2021 | 6207 | 0.140 |
Why?
|
Substance-Related Disorders | 3 | 2021 | 4421 | 0.140 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2003 | 1139 | 0.140 |
Why?
|
Hormones | 1 | 2001 | 866 | 0.140 |
Why?
|
Pregnancy Trimester, Second | 4 | 2010 | 737 | 0.140 |
Why?
|
Obesity | 1 | 2019 | 13090 | 0.140 |
Why?
|
Smoking | 5 | 2009 | 9077 | 0.130 |
Why?
|
Cohort Studies | 17 | 2017 | 41710 | 0.130 |
Why?
|
Sexual Dysfunctions, Psychological | 2 | 2016 | 193 | 0.130 |
Why?
|
Echocardiography | 1 | 2009 | 5037 | 0.130 |
Why?
|
Gestational Age | 5 | 2014 | 3617 | 0.130 |
Why?
|
Fertility Agents, Female | 1 | 2016 | 101 | 0.130 |
Why?
|
Risk Assessment | 11 | 2018 | 24295 | 0.130 |
Why?
|
Child Development | 3 | 2021 | 2327 | 0.130 |
Why?
|
Ultrasonography | 8 | 2013 | 5992 | 0.130 |
Why?
|
Incidence | 8 | 2024 | 21525 | 0.130 |
Why?
|
Drug Therapy, Combination | 5 | 2017 | 6307 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2020 | 10384 | 0.120 |
Why?
|
Reproducibility of Results | 6 | 2015 | 20144 | 0.120 |
Why?
|
Cross-Sectional Studies | 12 | 2024 | 26310 | 0.120 |
Why?
|
Serotonin | 2 | 2006 | 1045 | 0.120 |
Why?
|
Luteal Phase | 3 | 2006 | 138 | 0.120 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5514 | 0.120 |
Why?
|
Age Factors | 11 | 2006 | 18397 | 0.120 |
Why?
|
Risk | 6 | 2016 | 9602 | 0.120 |
Why?
|
Leuprolide | 1 | 2016 | 310 | 0.120 |
Why?
|
Schizophrenic Psychology | 2 | 2017 | 1647 | 0.120 |
Why?
|
Pregnancy Trimesters | 1 | 2015 | 197 | 0.120 |
Why?
|
Fear | 5 | 2009 | 1496 | 0.120 |
Why?
|
Progesterone Congeners | 1 | 1994 | 42 | 0.110 |
Why?
|
Forecasting | 1 | 2023 | 2936 | 0.110 |
Why?
|
Obstetric Labor Complications | 1 | 1996 | 240 | 0.110 |
Why?
|
Endometrial Neoplasms | 1 | 2003 | 1380 | 0.110 |
Why?
|
Retrospective Studies | 16 | 2024 | 81635 | 0.110 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2017 | 606 | 0.110 |
Why?
|
Hospitals, Psychiatric | 1 | 2014 | 318 | 0.100 |
Why?
|
Ebstein Anomaly | 1 | 1994 | 106 | 0.100 |
Why?
|
Telephone | 1 | 2016 | 629 | 0.100 |
Why?
|
Off-Label Use | 1 | 2014 | 185 | 0.100 |
Why?
|
Follicular Phase | 1 | 2013 | 143 | 0.100 |
Why?
|
Chicago | 1 | 2013 | 255 | 0.100 |
Why?
|
Diagnosis, Differential | 6 | 2024 | 12985 | 0.100 |
Why?
|
Mental Competency | 1 | 1993 | 179 | 0.100 |
Why?
|
Probability | 4 | 2002 | 2476 | 0.100 |
Why?
|
Universities | 3 | 2006 | 1004 | 0.100 |
Why?
|
Child | 5 | 2023 | 80668 | 0.100 |
Why?
|
Agoraphobia | 2 | 1989 | 177 | 0.100 |
Why?
|
Infant Behavior | 2 | 2011 | 156 | 0.090 |
Why?
|
Umbilical Arteries | 1 | 1991 | 77 | 0.090 |
Why?
|
Hyperbilirubinemia | 1 | 1991 | 74 | 0.090 |
Why?
|
Hyperandrogenism | 3 | 2006 | 46 | 0.090 |
Why?
|
Selection Bias | 1 | 2013 | 359 | 0.090 |
Why?
|
S-Adenosylmethionine | 5 | 2010 | 219 | 0.090 |
Why?
|
Levonorgestrel | 1 | 2011 | 76 | 0.090 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 609 | 0.090 |
Why?
|
Tetralogy of Fallot | 1 | 2016 | 629 | 0.090 |
Why?
|
Abortion, Induced | 3 | 2004 | 471 | 0.090 |
Why?
|
United States | 7 | 2021 | 72951 | 0.090 |
Why?
|
Pregnancy, Ectopic | 1 | 2012 | 146 | 0.090 |
Why?
|
Demography | 2 | 2008 | 1641 | 0.090 |
Why?
|
Polycystic Ovary Syndrome | 2 | 2006 | 391 | 0.090 |
Why?
|
Ear | 1 | 2011 | 172 | 0.090 |
Why?
|
Male | 34 | 2018 | 364142 | 0.090 |
Why?
|
Patient Selection | 4 | 2014 | 4252 | 0.090 |
Why?
|
Contraceptives, Oral, Combined | 2 | 2017 | 116 | 0.090 |
Why?
|
Contraceptive Agents, Female | 1 | 2011 | 122 | 0.090 |
Why?
|
Longitudinal Studies | 8 | 2018 | 14762 | 0.090 |
Why?
|
Asymptomatic Diseases | 1 | 2013 | 588 | 0.080 |
Why?
|
Attitude to Health | 2 | 2010 | 2021 | 0.080 |
Why?
|
Trisomy | 1 | 2011 | 260 | 0.080 |
Why?
|
Sex Distribution | 1 | 2014 | 2274 | 0.080 |
Why?
|
Drug Monitoring | 1 | 2015 | 962 | 0.080 |
Why?
|
Drug Combinations | 1 | 2015 | 2085 | 0.080 |
Why?
|
Benzhydryl Compounds | 1 | 2016 | 944 | 0.080 |
Why?
|
Fatigue | 2 | 2016 | 1555 | 0.080 |
Why?
|
Liver Function Tests | 1 | 2010 | 527 | 0.080 |
Why?
|
Child Behavior | 1 | 2014 | 864 | 0.080 |
Why?
|
Abdomen | 1 | 1995 | 1137 | 0.080 |
Why?
|
Folic Acid | 1 | 2015 | 1337 | 0.080 |
Why?
|
Estriol | 1 | 2008 | 53 | 0.080 |
Why?
|
Time Factors | 10 | 2014 | 40149 | 0.080 |
Why?
|
Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2008 | 30 | 0.080 |
Why?
|
Reference Values | 3 | 2011 | 4913 | 0.080 |
Why?
|
Predictive Value of Tests | 7 | 2017 | 15416 | 0.070 |
Why?
|
Abruptio Placentae | 1 | 1989 | 116 | 0.070 |
Why?
|
Primary Ovarian Insufficiency | 2 | 2018 | 104 | 0.070 |
Why?
|
Patient Satisfaction | 3 | 2014 | 3485 | 0.070 |
Why?
|
Thyrotropin | 3 | 2007 | 834 | 0.070 |
Why?
|
Neurologic Examination | 1 | 2011 | 913 | 0.070 |
Why?
|
Complementary Therapies | 2 | 2010 | 486 | 0.070 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 326 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2017 | 1663 | 0.070 |
Why?
|
Alprazolam | 4 | 1993 | 103 | 0.070 |
Why?
|
Fetal Growth Retardation | 1 | 1991 | 591 | 0.070 |
Why?
|
Triglycerides | 1 | 2015 | 2441 | 0.070 |
Why?
|
Apgar Score | 3 | 2005 | 125 | 0.070 |
Why?
|
Personality Inventory | 4 | 2009 | 1019 | 0.070 |
Why?
|
Glycogen | 2 | 2018 | 252 | 0.070 |
Why?
|
Students | 3 | 2006 | 1741 | 0.070 |
Why?
|
Behavior Therapy | 2 | 2025 | 886 | 0.070 |
Why?
|
Mental Health | 1 | 2021 | 3270 | 0.070 |
Why?
|
Blood Urea Nitrogen | 1 | 2007 | 189 | 0.070 |
Why?
|
Twins | 1 | 1988 | 341 | 0.070 |
Why?
|
Medicaid | 2 | 2017 | 2836 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3432 | 0.070 |
Why?
|
Psychometrics | 1 | 2016 | 3060 | 0.070 |
Why?
|
Cocaine | 1 | 1991 | 944 | 0.070 |
Why?
|
Norethindrone | 1 | 2006 | 52 | 0.070 |
Why?
|
Twins, Monozygotic | 1 | 1988 | 471 | 0.070 |
Why?
|
Robotics | 1 | 2013 | 807 | 0.070 |
Why?
|
Patient Dropouts | 2 | 2007 | 411 | 0.070 |
Why?
|
Lactobacillus | 2 | 2018 | 212 | 0.070 |
Why?
|
Diseases in Twins | 1 | 1988 | 447 | 0.070 |
Why?
|
Dyspareunia | 2 | 2018 | 48 | 0.070 |
Why?
|
Cholesterol | 1 | 2015 | 2903 | 0.070 |
Why?
|
Ovariectomy | 2 | 2018 | 612 | 0.070 |
Why?
|
Confusion | 1 | 2008 | 278 | 0.060 |
Why?
|
Practice Guidelines as Topic | 4 | 2007 | 7431 | 0.060 |
Why?
|
Delusions | 1 | 2008 | 300 | 0.060 |
Why?
|
Oligomenorrhea | 1 | 2006 | 42 | 0.060 |
Why?
|
Neuropsychological Tests | 2 | 2017 | 7119 | 0.060 |
Why?
|
Parity | 2 | 2007 | 931 | 0.060 |
Why?
|
Oxidative Stress | 1 | 2017 | 3139 | 0.060 |
Why?
|
Psychomotor Agitation | 1 | 2008 | 307 | 0.060 |
Why?
|
Menarche | 2 | 2006 | 532 | 0.060 |
Why?
|
Social Control Policies | 1 | 2005 | 9 | 0.060 |
Why?
|
Preoperative Care | 1 | 1995 | 2253 | 0.060 |
Why?
|
Student Health Services | 1 | 2005 | 40 | 0.060 |
Why?
|
Brain | 4 | 2021 | 27159 | 0.060 |
Why?
|
Urogenital Abnormalities | 1 | 2008 | 255 | 0.060 |
Why?
|
Metabolism | 1 | 2006 | 193 | 0.060 |
Why?
|
Methotrexate | 1 | 2012 | 1719 | 0.060 |
Why?
|
Haloperidol | 2 | 2002 | 394 | 0.060 |
Why?
|
Pandemics | 2 | 2023 | 8735 | 0.060 |
Why?
|
Risperidone | 2 | 2018 | 383 | 0.060 |
Why?
|
Creatine | 1 | 2007 | 424 | 0.060 |
Why?
|
Kidney Function Tests | 1 | 2007 | 685 | 0.060 |
Why?
|
Ganglionic Stimulants | 1 | 2004 | 18 | 0.060 |
Why?
|
Sex Factors | 5 | 2005 | 10619 | 0.060 |
Why?
|
Sexual Behavior | 1 | 2014 | 2192 | 0.060 |
Why?
|
Heart Rate | 2 | 2015 | 4207 | 0.060 |
Why?
|
Abortifacient Agents, Steroidal | 1 | 2004 | 22 | 0.060 |
Why?
|
Psychiatry | 2 | 2010 | 1715 | 0.060 |
Why?
|
Embryonic and Fetal Development | 2 | 2004 | 420 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2188 | 0.060 |
Why?
|
Logistic Models | 5 | 2014 | 13278 | 0.060 |
Why?
|
Body Mass Index | 4 | 2017 | 13050 | 0.050 |
Why?
|
Saliva | 1 | 2008 | 852 | 0.050 |
Why?
|
Cross-Over Studies | 1 | 2009 | 2108 | 0.050 |
Why?
|
Ovarian Function Tests | 1 | 2003 | 10 | 0.050 |
Why?
|
Mifepristone | 1 | 2004 | 151 | 0.050 |
Why?
|
Hysterectomy | 2 | 2018 | 863 | 0.050 |
Why?
|
Misoprostol | 1 | 2004 | 94 | 0.050 |
Why?
|
Organizational Policy | 1 | 2005 | 434 | 0.050 |
Why?
|
Amniocentesis | 2 | 2011 | 116 | 0.050 |
Why?
|
Carbamazepine | 3 | 2004 | 224 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2783 | 0.050 |
Why?
|
Amenorrhea | 1 | 2006 | 470 | 0.050 |
Why?
|
Menstruation | 1 | 2004 | 310 | 0.050 |
Why?
|
Video Games | 1 | 2025 | 202 | 0.050 |
Why?
|
Cytokines | 1 | 2017 | 7438 | 0.050 |
Why?
|
Asthma | 1 | 2021 | 6268 | 0.050 |
Why?
|
Mianserin | 1 | 2001 | 51 | 0.050 |
Why?
|
Pirenzepine | 1 | 2002 | 116 | 0.050 |
Why?
|
Uterine Hemorrhage | 1 | 2003 | 235 | 0.050 |
Why?
|
Neurology | 1 | 2010 | 785 | 0.050 |
Why?
|
Survival Analysis | 3 | 2007 | 10100 | 0.050 |
Why?
|
Laparoscopy | 1 | 2013 | 2039 | 0.050 |
Why?
|
Medical History Taking | 3 | 2017 | 779 | 0.050 |
Why?
|
Dysthymic Disorder | 1 | 2001 | 73 | 0.050 |
Why?
|
Epilepsy | 2 | 2010 | 3317 | 0.050 |
Why?
|
Causality | 1 | 2007 | 1252 | 0.050 |
Why?
|
Fetal Diseases | 3 | 2011 | 915 | 0.040 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2005 | 488 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 2004 | 966 | 0.040 |
Why?
|
Aged | 15 | 2020 | 171343 | 0.040 |
Why?
|
Hysterosalpingography | 1 | 2000 | 26 | 0.040 |
Why?
|
Personality | 1 | 2004 | 560 | 0.040 |
Why?
|
Odds Ratio | 4 | 2009 | 9661 | 0.040 |
Why?
|
Triazines | 2 | 2017 | 311 | 0.040 |
Why?
|
Weight Gain | 1 | 2010 | 2356 | 0.040 |
Why?
|
Smoking Cessation | 2 | 2009 | 2085 | 0.040 |
Why?
|
Birth Weight | 2 | 2014 | 2123 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12245 | 0.040 |
Why?
|
Regression Analysis | 2 | 2006 | 6329 | 0.040 |
Why?
|
Tranquilizing Agents | 1 | 1999 | 59 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4249 | 0.040 |
Why?
|
Ovulation | 1 | 2020 | 181 | 0.040 |
Why?
|
Pyridines | 1 | 2011 | 2888 | 0.040 |
Why?
|
Nicotine | 1 | 2004 | 680 | 0.040 |
Why?
|
Serotonin Agents | 1 | 1998 | 29 | 0.040 |
Why?
|
Nervous System Malformations | 1 | 2001 | 243 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2001 | 957 | 0.040 |
Why?
|
Somatoform Disorders | 1 | 2001 | 425 | 0.040 |
Why?
|
Health Status | 2 | 2016 | 4087 | 0.040 |
Why?
|
Educational Status | 1 | 2006 | 2510 | 0.040 |
Why?
|
Abortion, Spontaneous | 1 | 2003 | 536 | 0.040 |
Why?
|
Aggression | 1 | 2003 | 748 | 0.040 |
Why?
|
Tobacco Use Disorder | 1 | 2004 | 708 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3459 | 0.040 |
Why?
|
Vulvar Diseases | 1 | 2018 | 64 | 0.040 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2017 | 45 | 0.040 |
Why?
|
Boston | 3 | 2006 | 9346 | 0.040 |
Why?
|
Prognosis | 5 | 2017 | 29948 | 0.040 |
Why?
|
Tocolytic Agents | 1 | 1997 | 24 | 0.040 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2002 | 698 | 0.040 |
Why?
|
Inflammation | 1 | 2017 | 10860 | 0.040 |
Why?
|
Body Image | 1 | 2022 | 645 | 0.030 |
Why?
|
Magnesium Sulfate | 1 | 1997 | 73 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2014 | 4880 | 0.030 |
Why?
|
Recovery of Function | 1 | 2007 | 2976 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2003 | 1394 | 0.030 |
Why?
|
Indomethacin | 1 | 1997 | 323 | 0.030 |
Why?
|
Estrone | 1 | 2017 | 234 | 0.030 |
Why?
|
Blood Pressure | 4 | 2010 | 8533 | 0.030 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2020 | 364 | 0.030 |
Why?
|
Placenta | 1 | 2005 | 1725 | 0.030 |
Why?
|
Endocrine System Diseases | 1 | 1998 | 247 | 0.030 |
Why?
|
Exercise Therapy | 2 | 2014 | 938 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 2017 | 275 | 0.030 |
Why?
|
Chromosome Aberrations | 2 | 2011 | 1776 | 0.030 |
Why?
|
Health Services Research | 1 | 2004 | 1811 | 0.030 |
Why?
|
Motivation | 1 | 2006 | 2020 | 0.030 |
Why?
|
Cost of Illness | 1 | 2006 | 1949 | 0.030 |
Why?
|
Teaching Materials | 1 | 2016 | 85 | 0.030 |
Why?
|
Endosonography | 1 | 2000 | 626 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2010 | 3927 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2002 | 949 | 0.030 |
Why?
|
Self Report | 2 | 2017 | 3771 | 0.030 |
Why?
|
Translating | 1 | 2016 | 144 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2017 | 393 | 0.030 |
Why?
|
Decision Making | 2 | 2002 | 3951 | 0.030 |
Why?
|
Orgasm | 1 | 2014 | 62 | 0.030 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 1995 | 274 | 0.030 |
Why?
|
Health Behavior | 1 | 2005 | 2649 | 0.030 |
Why?
|
Urban Population | 1 | 2001 | 2040 | 0.030 |
Why?
|
Ambulatory Care | 2 | 1994 | 2779 | 0.030 |
Why?
|
Counseling | 1 | 2001 | 1552 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1631 | 0.030 |
Why?
|
Tyrosine | 1 | 2017 | 1425 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2023 | 2662 | 0.030 |
Why?
|
Research | 1 | 2021 | 1977 | 0.030 |
Why?
|
Myocardial Infarction | 2 | 1988 | 11513 | 0.020 |
Why?
|
Mental Health Services | 1 | 2024 | 1728 | 0.020 |
Why?
|
Patient Compliance | 1 | 2002 | 2694 | 0.020 |
Why?
|
Pain | 1 | 2007 | 5098 | 0.020 |
Why?
|
Papillary Muscles | 1 | 1972 | 192 | 0.020 |
Why?
|
Choroid Plexus | 1 | 1994 | 249 | 0.020 |
Why?
|
Quality Control | 1 | 2014 | 834 | 0.020 |
Why?
|
Meditation | 1 | 2014 | 256 | 0.020 |
Why?
|
Thiazoles | 1 | 2018 | 1529 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42577 | 0.020 |
Why?
|
Myocardial Contraction | 2 | 1993 | 1516 | 0.020 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2011 | 228 | 0.020 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2011 | 192 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2005 | 11218 | 0.020 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2011 | 247 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2533 | 0.020 |
Why?
|
Radiography | 1 | 2001 | 6968 | 0.020 |
Why?
|
Assertiveness | 1 | 2009 | 18 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3230 | 0.020 |
Why?
|
Endoscopy | 1 | 2000 | 1854 | 0.020 |
Why?
|
Neurotic Disorders | 1 | 2009 | 76 | 0.020 |
Why?
|
Fetus | 1 | 1997 | 1878 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2002 | 3618 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 14072 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2003 | 3967 | 0.020 |
Why?
|
Cysts | 1 | 1994 | 685 | 0.020 |
Why?
|
Receptors, Dopamine | 1 | 1990 | 291 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2717 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 3208 | 0.020 |
Why?
|
Dehydroepiandrosterone | 1 | 1989 | 249 | 0.020 |
Why?
|
Cervix Uteri | 1 | 2012 | 575 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 1991 | 1374 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2003 | 1528 | 0.020 |
Why?
|
Prolactin | 1 | 1990 | 627 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1794 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2005 | 4628 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2014 | 2351 | 0.020 |
Why?
|
Prenatal Diagnosis | 1 | 1994 | 1271 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2001 | 7841 | 0.020 |
Why?
|
Nitroglycerin | 1 | 1988 | 332 | 0.020 |
Why?
|
Sample Size | 1 | 2010 | 844 | 0.020 |
Why?
|
Informed Consent | 1 | 1993 | 1010 | 0.020 |
Why?
|
Cardiac Output | 4 | 1993 | 838 | 0.020 |
Why?
|
Hirsutism | 1 | 2006 | 66 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1972 | 0.020 |
Why?
|
Primary Health Care | 1 | 2002 | 4735 | 0.020 |
Why?
|
Administration, Oral | 5 | 1995 | 4018 | 0.020 |
Why?
|
Exercise Test | 1 | 1993 | 2188 | 0.020 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 1989 | 519 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 1988 | 687 | 0.010 |
Why?
|
Hydrocortisone | 2 | 1990 | 1838 | 0.010 |
Why?
|
Aging | 1 | 2003 | 8731 | 0.010 |
Why?
|
Texas | 1 | 2005 | 410 | 0.010 |
Why?
|
Angina Pectoris | 1 | 1988 | 956 | 0.010 |
Why?
|
Angina, Unstable | 1 | 1988 | 893 | 0.010 |
Why?
|
Lithium Carbonate | 1 | 2004 | 179 | 0.010 |
Why?
|
Arousal | 1 | 2009 | 1174 | 0.010 |
Why?
|
Schizophrenia | 1 | 2002 | 6976 | 0.010 |
Why?
|
Hemodynamics | 1 | 1993 | 4188 | 0.010 |
Why?
|
Diet | 1 | 2001 | 8088 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5874 | 0.010 |
Why?
|
Vascular Resistance | 2 | 1997 | 939 | 0.010 |
Why?
|
Clinical Trials as Topic | 5 | 1990 | 8045 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3576 | 0.010 |
Why?
|
Medroxyprogesterone | 1 | 2001 | 33 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1988 | 1241 | 0.010 |
Why?
|
Patient Care Team | 1 | 1993 | 2519 | 0.010 |
Why?
|
Infusions, Intravenous | 2 | 1997 | 2228 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1988 | 1791 | 0.010 |
Why?
|
Nuclear Family | 1 | 2002 | 311 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 1993 | 3935 | 0.010 |
Why?
|
Sampling Studies | 1 | 2002 | 614 | 0.010 |
Why?
|
Thyrotropin-Releasing Hormone | 2 | 1990 | 139 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5536 | 0.010 |
Why?
|
Personality Assessment | 1 | 2001 | 646 | 0.010 |
Why?
|
Occupations | 1 | 2002 | 516 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6490 | 0.010 |
Why?
|
Sleep Deprivation | 1 | 2006 | 848 | 0.010 |
Why?
|
Angiocardiography | 1 | 1979 | 149 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2869 | 0.010 |
Why?
|
Fetal Blood | 1 | 2005 | 1367 | 0.010 |
Why?
|
Infant, Premature | 1 | 2008 | 2120 | 0.010 |
Why?
|
Labor, Obstetric | 1 | 2001 | 313 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2003 | 2921 | 0.010 |
Why?
|
Tocolysis | 1 | 1997 | 18 | 0.010 |
Why?
|
Marital Status | 1 | 1999 | 426 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2006 | 36567 | 0.010 |
Why?
|
Family Characteristics | 1 | 2002 | 1002 | 0.010 |
Why?
|
Program Evaluation | 1 | 2005 | 2504 | 0.010 |
Why?
|
Community Health Services | 1 | 2001 | 659 | 0.010 |
Why?
|
Coronary Disease | 3 | 1993 | 5915 | 0.010 |
Why?
|
Aspirin | 1 | 1988 | 3135 | 0.010 |
Why?
|
Connecticut | 1 | 1976 | 365 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2001 | 59550 | 0.010 |
Why?
|
Physical Exertion | 1 | 1979 | 667 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 1988 | 2763 | 0.010 |
Why?
|
Prefrontal Cortex | 1 | 2006 | 2224 | 0.010 |
Why?
|
Testosterone | 1 | 2006 | 2495 | 0.010 |
Why?
|
Social Support | 1 | 2005 | 2191 | 0.010 |
Why?
|
Overweight | 1 | 2006 | 2446 | 0.010 |
Why?
|
Heart | 1 | 1988 | 4425 | 0.010 |
Why?
|
Death, Sudden | 1 | 1976 | 301 | 0.010 |
Why?
|
Random Allocation | 2 | 1989 | 2394 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1997 | 1478 | 0.010 |
Why?
|
Clomipramine | 1 | 1993 | 50 | 0.010 |
Why?
|
Desipramine | 1 | 1993 | 182 | 0.010 |
Why?
|
Age of Onset | 1 | 2000 | 3342 | 0.010 |
Why?
|
Chordae Tendineae | 1 | 1972 | 39 | 0.010 |
Why?
|
Anticoagulants | 1 | 1988 | 4855 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2002 | 2116 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1994 | 498 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11061 | 0.010 |
Why?
|
Systole | 1 | 1993 | 935 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4626 | 0.010 |
Why?
|
Radionuclide Imaging | 2 | 1988 | 1986 | 0.010 |
Why?
|
Hypertension | 2 | 1989 | 8616 | 0.010 |
Why?
|
Ataxia | 1 | 1991 | 307 | 0.000 |
Why?
|
Autopsy | 1 | 1972 | 1011 | 0.000 |
Why?
|
Protein-Losing Enteropathies | 1 | 1968 | 45 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 18075 | 0.000 |
Why?
|
Leukopenia | 1 | 1968 | 213 | 0.000 |
Why?
|
Stroke Volume | 2 | 1993 | 5618 | 0.000 |
Why?
|
Cerebral Hemorrhage | 1 | 1997 | 2654 | 0.000 |
Why?
|
Brain Diseases | 1 | 1994 | 1552 | 0.000 |
Why?
|
Heart Ventricles | 2 | 1979 | 3832 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1972 | 1029 | 0.000 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 1968 | 361 | 0.000 |
Why?
|
Myocardium | 1 | 1976 | 4765 | 0.000 |
Why?
|
Dexamethasone | 1 | 1990 | 1962 | 0.000 |
Why?
|
Immunity | 1 | 1968 | 1002 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 2009 | 21162 | 0.000 |
Why?
|
Animals | 1 | 1994 | 168930 | 0.000 |
Why?
|
Coronary Vessels | 1 | 1972 | 3100 | 0.000 |
Why?
|
Lymphocytes | 1 | 1968 | 2605 | 0.000 |
Why?
|
Cardiomyopathies | 1 | 1972 | 2059 | 0.000 |
Why?
|
Hospitalization | 1 | 1976 | 10823 | 0.000 |
Why?
|
Chromium Isotopes | 1 | 1968 | 28 | 0.000 |
Why?
|
Iodine Isotopes | 1 | 1968 | 79 | 0.000 |
Why?
|
Pericarditis, Constrictive | 1 | 1968 | 46 | 0.000 |
Why?
|
Metabolic Clearance Rate | 1 | 1968 | 361 | 0.000 |
Why?
|
Hypersensitivity, Delayed | 1 | 1968 | 491 | 0.000 |
Why?
|
Rheumatic Heart Disease | 1 | 1968 | 163 | 0.000 |
Why?
|
Skin Tests | 1 | 1968 | 630 | 0.000 |
Why?
|
Transplantation Immunology | 1 | 1968 | 540 | 0.000 |
Why?
|
Albumins | 1 | 1968 | 578 | 0.000 |
Why?
|
Electrocardiography | 1 | 1979 | 6408 | 0.000 |
Why?
|
Serum Albumin | 1 | 1968 | 675 | 0.000 |
Why?
|
Leukocyte Count | 1 | 1968 | 1606 | 0.000 |
Why?
|
Skin Transplantation | 1 | 1968 | 1097 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1968 | 4860 | 0.000 |
Why?
|
Proteins | 1 | 1968 | 6002 | 0.000 |
Why?
|